Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action

WOJCIECH TRYBUS, TEODORA KRÓL, EWA TRYBUS, ANNA KOPACZ-BEDNARSKA, GRZEGORZ KRÓL and EWA KARPOWICZ
Anticancer Research November 2017, 37 (11) 6087-6096;
WOJCIECH TRYBUS
1Department of Cell Biology and Electron Microscopy, Institute of Biology, The Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wojciech.trybus{at}ujk.edu.pl
TEODORA KRÓL
1Department of Cell Biology and Electron Microscopy, Institute of Biology, The Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EWA TRYBUS
1Department of Cell Biology and Electron Microscopy, Institute of Biology, The Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA KOPACZ-BEDNARSKA
1Department of Cell Biology and Electron Microscopy, Institute of Biology, The Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GRZEGORZ KRÓL
2Faculty of Management, University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EWA KARPOWICZ
1Department of Cell Biology and Electron Microscopy, Institute of Biology, The Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: An example of plant-derived compounds that may be of great importance in oncological therapy is emodin. The aim of this study was to evaluate the range of changes in the lysosomal compartment of HeLa cervical cancer cells treated with emodin. Materials and Methods: Changes in the lysosomal compartment were evaluated using microscopic techniques. In order to evaluate the activity of lysosomal enzymes and the permeability of the lysosomal membrane, a spectrophotometric technique was employed. Results: Emodin induced significant changes in the lysosomal compartment, manifesting as an increase in the number of lysosomes, autophagic vacuoles and the activity of lysosomal hydrolases. Emodin exhibited cytotoxic activity against lysosomes through lysosomal membrane damage with possible leaks of lysosomal hydrolases into the cytoplasm. Conclusion: Emodin induces degradation processes and promotes the death of tumor cells through a mechanism that occurs with clear involvement of the lysosomal compartment.

  • Emodin
  • lysosomal system
  • autophagy
  • cathepsins
  • apoptosis
  • permeability of lysosomal membrane

A major problem in the treatment of cancer is the removal of cells able to development immunological, chemotherapeutic and radiotherapeutic resistance. Avoidance of apoptotic death by tumor cells is one of the major barriers to cancer treatment, as the action of many classic antitumor drugs is based on triggering caspases that mediate apoptotic cell death (1). Hence, in recent years, much attention has been paid to new strategies for treatment using non-apoptotic mechanisms, i.e. autophagy, lysosomal cell death and necrosis, as they may be alternative mechanisms leading to cell death, including of cancer cells (2-4).

Anthraquinones, including emodin, the subject of our study, may be alternative agents in cancer therapy because they can induce cell death based on non-apoptotic mechanisms of action. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) was first isolated from extract of Rhamnus frangula L. (5). It has also been identified in the roots and rhizomes of many plant families such as Liliaceae (Aloe barbadensis Mill.) (6) and Polygonaceae (Rheum palmatum L., Rheum officinale B). Rheum officinale is used in traditional medicine, especially in Eastern Asia (7). Emodin has numerous pharmacological properties, including immunosuppressive (8), antibacterial (9), antifungal (10), antiviral (11), hepatoprotective (12), antioxidative (13). Emodin also has potential antitumor properties, the mechanism of which is still under investigation. Existing reports indicate that emodin is characterized by e.g. proapoptotic, prooxidative and antiangiogenic effects (14-19). To our knowledge, there are no data on the effect of emodin on the lysosomal system responsible for maintaining cell homeostasis, and in specific conditions i.e. the action of reactive oxygen species, some antitumor drugs, or lysosomotropic compounds indirectly for cell death. Therefore, the purpose of this work was to evaluate the range of biochemical, ultrastructural and morphological changes in the lysosomal compartment of tumor cells exposed to emodin.

Materials and Methods

In vitro culture conditions. HeLa cell line was grown under standard culture conditions in a CO2 DirectHeat (Thermo Fisher Scientific, Waltham, MA, USA) incubator. Cells came from the Department of Radiobiology and Immunology, UJK Kielce. The cells were grown on Dulbecco's Modified Eagle's medium (Thermo Scientific) supplemented with 10% fetal bovine serum with addition of 1% antibiotic mixture. Emodin was purchased from Sigma-Aldrich (St. Louis, MO, USA). The cells were exposed to emodin in a concentration range of 1-100 μM for 48 h.

Ultrastructural evaluation of cells under transmission electron microscopy. Cells were fixed in 3% glutaraldehyde using a modified method of Marzella and Glauman (20). Secondary fixation was performed in 2% osmium tetroxide (SPI Supplies, West Chester, PA, USA). The cells were immersed in Epon 812 resin (Serva Electrophoresis, Heidelberg, Germany) and polymerized. The preparations were cut on an EM UC7 ultramicrotome (Leica Microsystems, Wetzlar, Germany) and analyzed using a TECNAI G2 Spirit (FEI Company, Hillsboro, OR, USA) transmission electron microscope. Autophagic vacuoles were measured using TEM Imaging & Analysis 3.2 SP6 software (FEI Company). Organelle size was evaluated in groups of 50 cells treated with different concentration of emodin. Average values were calculated from the obtained data.

Marking the lysosomal compartment in cells using acridine orange. The induction of lysosomal membrane permeability by emodin was analyzed by the acridine orange translocation method. This dye is a lipophilic fluorochrome which accumulates at high concentrations in lysosomes, producing red fluorescence. Deprotonated acridine orange at low concentrations in the nucleus and cytosol exhibits green fluorescence (21). Marking of lysosomes with acridine orange was carried out according to the modified Harhaji et al. method (22). Cells in basal medium (control cells) and cells in medium treated with emodin were washed with PBS and then incubated with a solution of acridine orange (50 μg/ml) for 15 min. Images were made using a Nikon A1R confocal microscope (Nikon Instruments, Amsterdam, Netherlands).

Test of neutral red (NR) absorbance by lysosomes. Lysosomes were marked with a neutral red according to the modified methodology of Michalik et al. (23) using the phenomenon of NR absorption by lysosomes. The control cells and the cells with emodin were incubated with NR (50 μg/ml) (Sigma-Aldrich, St. Louis, MO, USA) for 3 h at 37°C and endocytosis was interrupted by washing the cells with PBS.

Enzymatic evaluation of activity of cathepsin D and L. Cells after 48 hours with emodin were trypsinized and submitted to the homogenization process. The lysosomal fraction of the cells was obtained according to the modified methodology of Marzella and Glauman (24). In the obtained lysosomal and extralysosomal fractions the activity of lysosomal cathepsin D (E.C. 3.4.23.5) and L (EC 3.4.22.15) was measured according to the method of Langner et al. (25) and the total protein content according to the method of Lowry as modified by Kirschke and Wiederanders (26). Activity of tested enzymes is expressed in μmol/mg protein/hour. Measurements were made by spectrophotometric method using a Nicolet Evolution spectrophotometer (Thermo Scientific). Biochemical results are the average of three independent experiments.

Evaluation of the degree of cytotoxicity of emodin to lysosomes: NR uptake assay. Cells treated with emodin at different concentrations were supplemented with NR at 50 μg/ml (according to Borenfreund's and Puerner's modified method) (27) for 3 h at 37°C to ensure dye absorption by the lysosomes. Cells were fixed, then solvent (ethanol/glacial acetic acid solution) was added in order to release the NR absorbed by the cells, with extraction for 10 min on a microplate shaker. The absorbance values were read at 540 nm and 690 nm on a Synergy 2 multimode microplate reader (BioTek, Winooski, VT, USA). The test was repeated in three independent experiments.

Visualization of apoptosis in cells: 4’,6-Diamidine-2-phenylindole (DAPI) staining. Evaluation of apoptosis in cells after administration of the test compound was made using a fluorescent marker (DAPI) to detect nuclear condensation and fragmentation. HeLa cells were cultured for 48 hours in medium with emodin (100 μM) or without (control cells). The culture medium was removed, 10 μg/ml DAPI solution (Sigma-Aldrich) was added and the cells were incubated for 15 minutes. Cells were then washed in PBS and analyzed in terms of morphological changes in nucleus under a Nikon Eclipse 80i fluorescence microscope (Nikon Instruments, Amsterdam, Netherlands).

Statistical analysis. The results of the study were analyzed using analysis of variance (ANOVA). Analyses of cell viability and evaluation of changes in lysosomal enzyme activity were performed using the Tukey test. Results of morphometric measurements of autophagic vacuoles were assessed using the Kruskal–Wallis non-parametric test. The differences were statistically significant at p<0.05.

Results

Growth of degradation processes in HeLa cells induced by emodin. Even at a concentration of 1 μM emodin, changes appeared compared with the control (Figure 1A) indicating an increase in biosynthesis, which is manifested by swelling of Golgi apparatus cisternae and enlargement of channels of the rough endoplasmic reticulum (Figure 1B). As the concentration of emodin increased, increase in degradation processes was induced, as indicated by the intense accumulation of a very large number of secondary lysosomes (Figure 1D) and autophagic vacuoles at various stages of formation (Figure 1C). They were limited by a double membrane, derived from rough endoplasmic reticulum (Figure 1E). They contained material at varying degrees of digestion (Figure 1F), often strongly degraded and electron-dense (Figure 1G). There was also a statistically significant increase in the size of vacuoles with increasing emodin concentration (Figure 2). As the concentration of emodin increased, there was also a progressive reduction in the cisternae of the Golgi apparatus and the rough endoplasmic reticulum (Figure 1F). Numerous and very swollen mitochondria, with a clear matrix with damaged cristae, and cells in late-stage apoptosis showing disintegration into numerous apoptotic bodies containing, e.g. nuclear fragments, (Figure 1 H) were also apparent.

Increase in the number of lysosomes and autophagic vacuoles induced by emodin. Cells exposed to emodin at 1 μM showed a stimulatory effect on the activity of the lysosomal system reflected by an increase in the number of lysosomes that absorbed neutral red (Figure 3B). Emodin at a concentration range of 15-30 μM caused significant activation of the lysosomal system in the form of the presence of very numerous lysosomes and numerous small cytoplasmic vacuoles (Figure 3C and D). A concentration of 60 μM emodin induced an increased number of cytoplasmic vacuoles and autophagic vacuoles containing large amounts of absorbed dye (Figure 3E). The highest range of changes was demonstrated in cells incubated with emodin at 100 μM, where few lysosomes and vacuoles and very numerous apoptotic cells were revealed (Figure 3F).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Ultrastructure of HeLa cells after 48-h incubation in basal medium (control; A) and when exposed to different concentrations of emodin: 1 μM (B), 15 μM (C), 30 μM (D), 45 μM (E), 60 μM (F) and 100 μM (G,H). Magnification ×16,500. Nucleus (N), mitochondria (M), Golgi apparatus (AG), autophagic vacuoles (VA), primary (Lp) and secondary (Ls) lysosomes, and apoptotic bodies (AB) are visible in the cytoplasm.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Changing size of autophagic vacuoles in HeLa cells after 48-h exposure to different concentrations of emodin. Results are the mean±SD of 50 counted cells (for each group). Differences were confirmed to be statistically significant at: ***p<0.001.

Increase of permeabilization of lysosomal membrane depends on the concentration of emodin. At a concentration of 1 μM emodin, numerous lysosomes and cells with cytoplasmic vacuolization were observed (Figure 4B). Cells exposed to 15 and 30 μM emodin were characterized by the highest intensification of red fluorescence. This indicates a significant increase in the activity of the lysosomal system, expressed by an increase in the number of lysosomes and vacuoles (Figure 4C and D). Cell exposure to emodin at a concentration of 60 μM resulted in visible fluorescent color saturation of the cytoplasmic degradation site, i.e. in autophagic vacuoles, as well as the presence of cells with gradual suppression of fluorescent color in lysosomes (Figure 4E). The highest used concentration (100 μM) of emodin induced significant gradual of emission of orange fluorescence in the marked, very sparse lysosomes (Figure 4F).

Change in cathepsin D and L activity is dependent on the concentration of emodin. Incubation of cells with emodin led to increased lysosomal membrane permeability, resulting in a highly statistically significant decrease in cathepsin D and L activity in the lysosomal fraction, while the extralysosomal fraction was characterized by a highly statistically significant increase in the activity of proteolytic enzymes (Figure 5).

The cytotoxic effect of emodin on lysosomes of tumor cells (NR test). From the lysosomal NR uptake assay, emodin was found to statistically significant reduce cell viability (Figure 6). A 50% reduction in viability (IC50) in the examined cells was demonstrated to occur at an emodin concentration of 39.084 μM. A 48-h exposure to 80 μM of emodin caused a further disturbance of lysosomal membrane integrity, resulting in a decrease in cell viability to 15.86%. Reduction in HeLa cell viability of 90% (IC90) was demonstrated at an emodin concentration of 93.814 μM.

Induction of apoptosis in HeLa cells is enhanced by emodin. HeLa cells exposed to emodin at 100 μM for 48 h clearly exhibited apoptosis (imaging by DAPI staining). Dying nuclei of cells resulted in an increase in the number of nuclei exhibiting specific symptoms characteristic of apoptosis, such as the chromatin condensation and nuclear fragmentation seen in Figure 7B.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

HeLa cells after 48-h incubation in basal medium (control; A) and when exposed to different concentrations of emodin: 1 μM (B), 15 μM (C), 30 μM (D), 60 μM (E) and 100 μM (F). Cells were dyed with neutral red: lysosomes (L), cytoplasmic vacuoles (CV), autophagic vacuoles (AV), and apoptotic cells (AC) can be clearly seen. Magnification ×4,000.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

HeLa cells after 48-h incubation in basal medium (control; A) and when exposed to different concentrations of emodin: 1 μM (B), 15 μM (C), 30 μM (D), 60 μM (E) and 100 μM (F). Cells were stained with acridine orange: lysosomes (L) (red emission), autophagic vacuoles (VA), cytoplasmic vacuoles (VC) are clearly visible. Green fluorescence of cytoplasm. Magnification ×4,000.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Activity (mean±SD) of cathepsin D and L in the lysosomal and extralysosomal fraction of HeLa cells after 48 h of exposure to different concentrations of emodin. Differences were confirmed to be statistically significant at: **p<0.01; ***p<0.001.

Discussion

Despite the intensive development of medical research, cancer is currently the second leading cause of death in humans (28, 29). The main weakness of anticancer therapy is the phenomenon of cellular resistance to cytostatics. One goal of modern medicine is to find new strategies which would allow the resistance of tumor cells to the therapies used to be overcome, and to discover the mechanisms leading to the development of such resistance, including multidrug resistance (30, 31). The development of cell resistance to chemotherapy involves, e.g. reduction of drug penetration into the cell and drug transport between the cell nucleus and cytoplasm, activation of detoxification systems, activation of DNA repair mechanisms, and the ability of tumor cells to disrupt the regulation of drug-induced apoptosis (30-32). Resistance of cancer cells, both initial and acquired, to commonly used chemotherapeutics is a serious problem in the treatment of cancer (32). Hence, there is a constant search for new antitumor compounds that have the ability to induce different mechanisms leading to cell death, including lysosomes, with emodin being an example of such compounds. The present study found that this compound modulates the activation and differentiation of the lysosomal compartment of HeLa cells, as evidenced by the emodin concentration-dependent increase in the number of NR (Figure 3C and D) and acridine orange (Figure 4C and D) labelled lysosomes, as well as by vacuoles packed with highly degraded material (Figure 1E-G). The induction of autophagic processes occurring in the examined tumor cells is also confirmed by the morphometric measurements (Figure 2), which at a 100 μM concentration showed a statistically significant increase in the dimensions of autophagic vacuoles (by 282%) relative to the vacuole volume in the control cells. The demonstrated reduction of rough endoplasmic reticulum and cisternae of the Golgi apparatus (Figure 1F) additionally indicates that a macroautophagy process was occuring, in which the membranes of these organelles can be used to surround the degraded material (33, 34).

From the available literature, it appears that standard anticancer drugs, e.g. taxol, vinblastine, vincristine and colchicine, also have the ability to induce and modulate the process of autophagy (35-42) which makes emodin similar in terms of mechanism of action. The induction of autophagy in tumor cells is, as the literature suggests, a desirable form of cancer treatment strategy, especially when cells are resistant to apoptosis (43, 44).

Studies show that pro-apoptotic effects of emodin are not only related to the mitochondrial pathway (14-19), but also to the lysosomal system. The application of emodin in a concentration of 60 μM and 100 μM resulted in nearly complete suppression of the red fluorescent orange acridine (Figure 4E). This indicates an emodin-dependent damage to the lysosomal membrane, which is the point of accumulation of the indicator used. Acridine orange is a non-enzymatic marker of lysosomal permeability and its intensity is directly proportional to the degree of acidity and volume of the lysosomal compartment (21, 45). Moreover, the NR test showed that when high concentrations of emodin were used, absorption of NR by lysosomes was inhibited (Figure 6). This confirms the increased permeability of the lysosomal membrane with possible leaks of lysosomal hydrolases into the cytoplasm of the cell, which has also been demonstrated in biochemical studies (Figure 5). This may indicate high accumulation of emodin in lysosomes and induction of apoptotic processes in tumor cells (Figures 1H, 3F, 7B) with a lysosomal compartment.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

HeLa cell viability determined by neutral red (NR) uptake assay after 48-h exposure to different concentrations of emodin. Differences were confirmed to be statistically significant at: ***p<0.001. IC50/IC90: 39.08±0.86 μM/93.81±0.75 μM.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Apoptosis observed in HeLa cells using 4’,6-Diamidine-2-phenylindole staining. Cells were exposed or not to emodin at 100 μM for 48 h. Control cells (not exposed to the test agent) showed normal nuclear morphology (A). Cells exposed to emodin showed chromatin condensation (CC) and nuclear fragmentation (NF) (B). Magnification ×400.

Cathepsins are proteolytic enzymes, commonly thought to be the cell death indicator released from lysosomes as a consequence of their membrane damage (46). Leakage of the lysosomal membrane may be a potentially lethal event for tumor cells because the presence of lysosomal proteases in the cytosol can cause digestion of important cellular proteins and the activation of additional enzymes, including of caspases (21, 47), thus inducing caspase-dependent apoptosis.

Conclusion

The results show that emodin induces degradation processes in the studied tumor cells. Emodin at high concentrations was also cytotoxic against lysosomes. Destabilizing lysosomal membranes caused increased lysosomal permeability and cathepsin leakage into the cytoplasm, inducing apoptosis. The demonstrated induction of autophagy and apoptosis involving the lysosomal compartment in cervical cancer cells may indicate an additional mechanism of anticancer action of emodin.

Acknowledgements

This work was supported by Jan Kochanowski University, grant: 066/R/11.

Footnotes

  • Conflicts of Interest

    All Authors have read the Journal's policy on disclosure of potential conflicts of interest and have none to declare.

  • Received June 13, 2017.
  • Revision received July 11, 2017.
  • Accepted July 12, 2017.
  • Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Hanahan D,
    2. Weinberg RA
    : The hallmarks of cancer. Cell 100: 57-70, 2000.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Kroemer G,
    2. Jäättelä M
    : Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886-897, 2005.
    OpenUrlCrossRefPubMed
    1. Rammer P,
    2. Groth-Pedersen L,
    3. Kirkegaard T,
    4. Daugaard M,
    5. Rytter A,
    6. Szyniarowski P,
    7. Høyer-Hansen M,
    8. Povlsen LK,
    9. Nylandsted J,
    10. Larsen JE,
    11. Jäättelä M
    : BAMLET activates a lysosomal cell death program in cancer cells. Mol Cancer Ther 9: 24-32, 2010.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Yang ZJ,
    2. Chee ChE,
    3. Huang S,
    4. Sinicrope FA
    : Autophagy modulation for cancer therapy. Cancer Biol Ther 11: 169-176, 2011.
    OpenUrlCrossRefPubMed
  4. ↵
    1. De La Rue W,
    2. Treas FRS,
    3. Müller H
    : On some constituents of rhubarb. Q J Chem Soc 10: 298-307, 1858.
    OpenUrl
  5. ↵
    1. Choi S,
    2. Chung MH
    : A review on the relationship between Aloe vera components and their biologic effects. Semin Integr Med 1: 53-62, 2003.
    OpenUrl
  6. ↵
    1. Cui YT,
    2. Liu B,
    3. Xie J,
    4. Xu P,
    5. Habte-Tsion HM,
    6. Zhang YY
    : The effect of emodin on cytotoxicity, apoptosis and antioxidant capacity in the hepatic cells of grass carp (Ctenopharyngodon idellus). Fish Shellfish Immunol 38: 74-79, 2014.
    OpenUrl
  7. ↵
    1. Huang HC,
    2. Chang JH,
    3. Tung SF,
    4. Wu RT,
    5. Foegh ML,
    6. Chu SH
    : Immunosuppressive effect of emodin, a free radical generator. Eur J Pharmacol 211: 359-64, 1992.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Chukwujekwu JC,
    2. Coombes PH,
    3. Mullholand DA,
    4. Van Staden J
    : Emodin, an antibacterial anthraquinone from the roots of Cassia occidentaliss. S Afr J Bot 72: 295-297, 2006.
    OpenUrl
  9. ↵
    1. Kremer D,
    2. Kosalec I,
    3. Locatelli M,
    4. Epifano F,
    5. Genovese S,
    6. Carlucci G,
    7. Zovko Končić M
    : Anthraquinone profiles, antioxidant and antimicrobial properties of Frangula rupestris (Scop.) Schur and Frangula alnus Mill. Bark Food Chem 131: 1174-1180, 2012.
    OpenUrl
  10. ↵
    1. Xiong HR,
    2. Luo J,
    3. Hou W,
    4. Xiao H,
    5. Yang ZQ
    : The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo. J Ethnopharmacol 133: 718-23, 2011.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Lee BH,
    2. Huang YY,
    3. Duh PD,
    4. Wu SC
    : Hepatoprotection of emodin and Polygonum multiflorum against CCl(4)-induced liver injury. Pharm Biol 3: 351-9, 2012.
    OpenUrl
  12. ↵
    1. Du Y,
    2. Ko KM
    : Effects of emodin treatment on mitochondrial ATP generation capacity and antioxidant components as well as susceptibility to ischemia-reperfusion injury in rat hearts: Single versus multiple doses and gender difference. Life Sci 77: 2770-2782, 2005.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Chen YC,
    2. Shen SC,
    3. Lee WR,
    4. Hsu FL,
    5. Lin HY,
    6. Ko CH,
    7. Tseng SW
    : Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol 64: 1713-1724, 2002.
    OpenUrlCrossRefPubMed
    1. Chun-Guang W,
    2. Jun-Qing Y,
    3. Bei-Zhong L,
    4. Dan-Ting J,
    5. Chong W,
    6. Liang Z,
    7. Dan Z,
    8. Yan W
    : Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol 627: 33-41, 2010.
    OpenUrlPubMed
    1. Lee HZ
    : Protein kinase C involvement in aloe-emodin and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol 134: 1093-1103, 2001.
    OpenUrlCrossRefPubMed
    1. Jing X,
    2. Ueki N,
    3. Cheng J,
    4. Imanishi H,
    5. Hada T
    : Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res 93: 874-882, 2002.
    OpenUrlCrossRef
    1. Lin SY,
    2. Lai WW,
    3. Ho ChCh,
    4. Yu FS,
    5. Chen GW,
    6. Yang JS,
    7. Liu KCh,
    8. Lin ML,
    9. Wu PP,
    10. Fan MJ,
    11. Chung JG
    : Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29: 327-336, 2009.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Huang Z,
    2. Chen G,
    3. Shi P
    : Emodin-induced apoptosis in human breast cancer BCap-37 cells through the mitochondrial signaling pathway. Arch Pharm Res 31: 742-748, 2008.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Marzella L,
    2. Glaumann H
    : Increased degradation In rat liver induced by vinblastine. II. Morphological characterization. Lab Invest 42: 18-27, 1980.
    OpenUrl
  16. ↵
    1. Boya P,
    2. Kroemer G
    : Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451, 2008.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Harhaji L,
    2. Isakovic A,
    3. Raicevic N,
    4. Markovic Z,
    5. Todorovic-Markovic B,
    6. Nikolic N,
    7. Vranjes-Djuric S,
    8. Markovic I,
    9. Trajkovic V
    : Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 568: 89-98, 2007.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Michalik M,
    2. Pierzchalska M,
    3. Pabiańczyk-Kulka A,
    4. Korohoda W
    : Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts. Eur J Pharmacol 475: 1-10, 2003.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Marzella L,
    2. Glaumann H
    : Increased degradation in rat liver induced by vinblastine. I. Biochemical characterization. Lab Invest 42: 8-17, 1980.
    OpenUrl
  20. ↵
    1. Langner J,
    2. Wakil A,
    3. Zimmermann M,
    4. Ansorge S,
    5. Bohley P,
    6. Kirschke H,
    7. Wiederanders B
    : Aktivitätsbestimmung proteolytischer Enzyme mit Azokasein als Substrat. Acta Biol Med Ger 31: 1-18, 1973.
    OpenUrlPubMed
  21. ↵
    1. Kirschke H,
    2. Wiederanders B
    : Methoden zur Aktivitätsbestimmung von Proteinasen. Martin-Luther-Universität Halle-Wittenberg Wissenschaftliche Beitrage Halle/Salle pp. 11-17, 1984.
  22. ↵
    1. Borenfreund E,
    2. Puerner JA
    : Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24: 119-124, 1985.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Torre LA,
    2. Bray F,
    3. Siegel RL,
    4. Ferlay J,
    5. Lortet-Tieulent J,
    6. Jemal A
    : Global cancer statistics. CA Cancer J Clin 65: 87-108, 2012.
    OpenUrl
  24. ↵
    1. Siegel RL,
    2. Miller KD,
    3. Jemal A
    : Cancer statistics. CA Cancer J Clin 66: 7-30, 2016.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Gillet JP,
    2. Gottesman MM
    : Mechanisms of multidrug resistance in cancer. Methods Mol Biol 596: 47-76, 2010.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Gottesman MM
    : Mechanisms of cancer drug resistance. Annu Rev Med 53: 615-627, 2002.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Zahreddine H,
    2. Borden KLB
    : Mechanisms and insights into drug resistance in cancer. Front Pharmacol 4: 1-8, 2013.
    OpenUrlPubMed
  28. ↵
    1. Geng J,
    2. Klionsky DJ
    : The Golgi as a potential membrane source for autophagy. Autophagy 6: 950-951, 2010.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Mijaljica D,
    2. Prescott M,
    3. Devenish RJ
    : Endoplasmic reticulum and Golgi complex: Contributions to and turnover by, autophagy. Traffic 7: 1590-1595, 2006.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Aredia F,
    2. Ortiz LMG,
    3. Giansanti V,
    4. Scovassi AI
    : Autophagy and cancer. Cells 1: 520-534, 2006.
    OpenUrl
    1. Janku F,
    2. McConkey DJ,
    3. Hong DS,
    4. Kurzrock R
    : Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8: 528-39, 2011.
    OpenUrlCrossRefPubMed
    1. Esteve JM,
    2. Knecht E
    : Mechanisms of autophagy and apoptosis: Recent developments in breast cancer cells. World J Biol Chem 2: 232-238, 2011.
    OpenUrlCrossRefPubMed
    1. Wang XP,
    2. Chen TS,
    3. Sun L,
    4. Cai JY,
    5. Wu MQ,
    6. Mok M
    : Live morphological analysis of taxol-induced cytoplasmic vacuolization in human lung adenocarcinoma cells. Micron 39: 1216-21, 2008.
    OpenUrlPubMed
    1. Król T,
    2. Schmidt M,
    3. Kołątaj A,
    4. Witek B
    : Vinblastine-induced autophagy in mouse liver. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 107: 165-169, 1994.
    OpenUrl
    1. Król T
    : Vincristine-induced autophagy in mouse liver. Acta Biol Cracov series Zool 38: 5-8, 1996.
    OpenUrl
    1. Król T
    : Influence of colchicine on autodegradation in mouse hepatocytes. Acta Biol Cracov series Zool 40: 31-39, 1998.
    OpenUrl
  31. ↵
    1. Król T
    : Activity of lysosomal system in mouse liver after taxol administration. Gen Pharmac 30: 239-243, 1998.
    OpenUrlPubMed
  32. ↵
    1. Liu B,
    2. Bao JK,
    3. Yang JM,
    4. Cheng Y
    : Targeting autophagic pathways for cancer drug discovery. Chin J Cancer 32: 113-120, 2013.
    OpenUrl
  33. ↵
    1. Mathew R
    : Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Paglin S,
    2. Hollister T,
    3. Delohery T,
    4. Hackett N,
    5. McMahill M,
    6. Sphicas E,
    7. Domingo D,
    8. Yahalom J
    : A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444, 2001.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Mrschtik M,
    2. Ryan KM
    : Lysosomal proteins in cell death and autophagy. FEBS Journal 282: 1858-1870, 2015.
    OpenUrl
  36. ↵
    1. Guicciardi ME,
    2. Leist M,
    3. Gores GJ
    : Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 37, Issue 11
November 2017
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action
WOJCIECH TRYBUS, TEODORA KRÓL, EWA TRYBUS, ANNA KOPACZ-BEDNARSKA, GRZEGORZ KRÓL, EWA KARPOWICZ
Anticancer Research Nov 2017, 37 (11) 6087-6096;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action
WOJCIECH TRYBUS, TEODORA KRÓL, EWA TRYBUS, ANNA KOPACZ-BEDNARSKA, GRZEGORZ KRÓL, EWA KARPOWICZ
Anticancer Research Nov 2017, 37 (11) 6087-6096;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe
  • Induction of Mitotic Catastrophe in Human Cervical Cancer Cells After Administration of Aloe-emodin
  • Google Scholar

More in this TOC Section

  • Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
  • MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
Show more Experimental Studies

Keywords

  • Emodin
  • lysosomal system
  • autophagy
  • Cathepsins
  • apoptosis
  • permeability of lysosomal membrane
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire